Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance

Topcu S., Tok D., ÇALIŞKAN M., Özçimen E. E. , Güllü H., Uçkuyu A., ...More

CLINICAL ENDOCRINOLOGY, vol.65, no.1, pp.75-80, 2006 (Peer-Reviewed Journal) identifier

  • Publication Type: Article / Article
  • Volume: 65 Issue: 1
  • Publication Date: 2006
  • Doi Number: 10.1111/j.1365-2265.2006.02551.x
  • Journal Name: CLINICAL ENDOCRINOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.75-80

Abstract

Background Women with polycystic ovary syndrome (PCOS) are thought to have increased cardiovascular risk. Metformin therapy reduces whole-body insulin resistance (IR) in patients with type-2 diabetes mellitus (DM).